array:24 [ "pii" => "S0210480609742263" "issn" => "02104806" "doi" => "10.1016/S0210-4806(09)74226-3" "estado" => "S300" "fechaPublicacion" => "2009-01-01" "aid" => "74226" "copyright" => "Asociación Española de Urología (AEU)" "copyrightAnyo" => "2009" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Urol Esp. 2009;33:747-54" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1818 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 962 "PDF" => 849 ] ] "itemSiguiente" => array:18 [ "pii" => "S0210480609742275" "issn" => "02104806" "doi" => "10.1016/S0210-4806(09)74227-5" "estado" => "S300" "fechaPublicacion" => "2009-01-01" "aid" => "74227" "copyright" => "Asociación Española de Urología (AEU)" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Urol Esp. 2009;33:755-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1521 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 738 "PDF" => 777 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Nefrectomía radical laparoscópica en piezas quirúrgicas de gran tamaño" "tienePdf" => array:2 [ 0 => "es" 1 => "en" ] "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "755" "paginaFinal" => "758" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Laparoscopic radial nephrectomy in big surgical specimens" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:2 [ "es" => true "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sergio Alonso, Gregorio, S. Sánchez, C. Soler, A. Rando, M. Girón, J. Ángel Tabernero Gómez, A. Aguilera, Jesús Cisneros Ledo, Javier de la Peña Barthel" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Sergio" "apellidos" => "Alonso" ] 1 => array:1 [ "apellidos" => "Gregorio" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Sánchez" ] 3 => array:2 [ "nombre" => "C." "apellidos" => "Soler" ] 4 => array:2 [ "nombre" => "A." "apellidos" => "Rando" ] 5 => array:2 [ "nombre" => "M." "apellidos" => "Girón" ] 6 => array:2 [ "nombre" => "J." "apellidos" => "Ángel Tabernero Gómez" ] 7 => array:2 [ "nombre" => "A." "apellidos" => "Aguilera" ] 8 => array:2 [ "nombre" => "Jesús" "apellidos" => "Cisneros Ledo" ] 9 => array:2 [ "nombre" => "Javier" "apellidos" => "de la Peña Barthel" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480609742275?idApp=UINPBA00004N" "url" => "/02104806/0000003300000007/v1_201304251940/S0210480609742275/v1_201304251940/es/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0210480609742251" "issn" => "02104806" "doi" => "10.1016/S0210-4806(09)74225-1" "estado" => "S300" "fechaPublicacion" => "2009-01-01" "aid" => "74225" "copyright" => "Asociación Española de Urología (AEU)" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Actas Urol Esp. 2009;33:741-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1819 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 903 "PDF" => 908 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "El índice de masa corporal y la dieta afectan el desarrollo del cáncer de próstata" "tienePdf" => array:2 [ 0 => "es" 1 => "en" ] "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "741" "paginaFinal" => "746" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Body mass index and diet affect prostate cancer development" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:2 [ "es" => true "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Constanza M. López Fontana, Gabriela M. Recalde Rincón, Diego. Messina Lombino, Ana L. Uvilla Recupero, Rafael F. Pérez Elizalde, José D. López Laur" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Constanza M." "apellidos" => "López Fontana" ] 1 => array:2 [ "nombre" => "Gabriela M." "apellidos" => "Recalde Rincón" ] 2 => array:2 [ "nombre" => "Diego." "apellidos" => "Messina Lombino" ] 3 => array:2 [ "nombre" => "Ana L." "apellidos" => "Uvilla Recupero" ] 4 => array:2 [ "nombre" => "Rafael F." "apellidos" => "Pérez Elizalde" ] 5 => array:2 [ "nombre" => "José D." "apellidos" => "López Laur" ] ] ] ] ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480609742251?idApp=UINPBA00004N" "url" => "/02104806/0000003300000007/v1_201304251940/S0210480609742251/v1_201304251940/es/main.assets" ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Hipogonadismo prolongado tras la suspensión de tratamiento hormonal en pacientes con cáncer de próstata" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "747" "paginaFinal" => "754" ] ] "autores" => array:2 [ 0 => array:4 [ "autoresLista" => "I. Federico Rodríguez-Rubio Cortadellas, Miguel E. Jiménez Romero, Delfín González Moreno, Sofía Garrido Insúa" "autores" => array:4 [ 0 => array:4 [ "nombre" => "I." "apellidos" => "Federico Rodríguez-Rubio Cortadellas" "email" => array:1 [ 0 => "frubio@pulso.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">**</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Miguel E." "apellidos" => "Jiménez Romero" ] 2 => array:2 [ "nombre" => "Delfín" "apellidos" => "González Moreno" ] 3 => array:2 [ "nombre" => "Sofía" "apellidos" => "Garrido Insúa" ] ] "afiliaciones" => array:1 [ 0 => array:1 [ "entidad" => "Área de Medicina Preventiva. Facultad de Medicina. Universidad de Cádiz, España" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "**" "correspondencia" => "Correspondencia autor: Dr. Federico I. Rodríguez-Rubio Cortadellas Servicio de Urología. Hospital Universitario Puerto Real Carretera Nacional IV, Km 665 - 11510 Puerto Real, Cádiz Tel.: 956 005 000" ] ] ] 1 => array:3 [ "autoresLista" => "José P. Novalbos Ruiz" "autores" => array:1 [ 0 => array:3 [ "nombre" => "José P." "apellidos" => "Novalbos Ruiz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Servicio de Urología. Hospital Universitario Puerto Real. Departamento de Cirugía. Universidad de Cádiz, España" "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Prolonged hypogonadism after cessation of androgen deprivation therapy for prostate cancer" ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec89062" "palabras" => array:5 [ 0 => "Cáncer de próstata" 1 => "Supresión androgénica intermitente" 2 => "Testosterona" 3 => "Antígeno prostático específico" 4 => "Estudio prospectivo" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words" "identificador" => "xpalclavsec89063" "palabras" => array:5 [ 0 => "Prostate cancer" 1 => "Intermittent androgen supression" 2 => "Testosterone" 3 => "Prostate-specific antigen" 4 => "Prospective studies" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span class="elsevierStyleSectionTitle">Objetivos</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Estudiar los niveles de LH, testosterona y PSA tras suspender el tratamiento prolongado con análogos LH-RH</p> <span class="elsevierStyleSectionTitle">Material y Método</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Se estudió la evolución hormonal de 29 pacientes a los que se les retiró el tratamiento. Los pacientes previamente habían seguido tratamiento con análogo LH-RH por más de un año y con LH<2 mUI/mL y testosterona <2,8 ng/mL. Se determinó mensualmente la LH, testosterona y PSA junto con valoración clínica. Se reinicia el tratamiento y el tiempo de seguimiento finaliza ante la presencia de progresión clínica y/o PSA ? 10 ng/mL. Se realizó descripción de la cohorte, el cálculo de supervivencia mediante Kaplan-Meier y regresión de Cox.</p> <span class="elsevierStyleSectionTitle">Resultados</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">El tiempo medio sin tratamiento de la serie fue de 35 meses (IC 95% 15,7-54,2 meses). El 17% de los pacientes presentaron hipogonadismo prolongado (>24 meses). La recuperación del eje LH-T-PSA, cuando se produjo, siguió la secuencia esperada. Las variables que influyeron en el tiempo de recuperación del PSA fueron el PSA pretratamiento y la asociación de antiandrógeno.</p> <span class="elsevierStyleSectionTitle">Conclusiones</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Tras retirar el tratamiento prolongado con análogos LH-RH la mayoría de los pacientes recuperan los niveles de LH-T-PSA si bien un subgrupo se mantienen hipogonádicos más de 24 meses. Palabras clave: Cáncer de próstata. Supresión androgénica intermitente. Testosterona. Antígeno prostático específico. Estudio prospectivo.</p>" ] "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span class="elsevierStyleSectionTitle">Objectives</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">To study the levels of LH, testosterone and PSA after suspending prolonged treatment with LH-RH analogs.</p> <span class="elsevierStyleSectionTitle">Materials and Method</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Hormonal evolution was studied in 29 patients from whom treatment had been withdrawn. The patients had previously been receiving treatment with LH-RH analog for more than one year, and with LH< 2 mUI/mL and testosterone <2.8 ng/mL. LH, testosterone and PSA were determined monthly, together with clinical assessment. The treatment was re-initiated and the period of monitoring ended before the presence of clinical progression and/or PSA ? 10 ng/mL. The cohort was described and survival was calculated using Kaplan-Meier and Cox regression.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">The mean period of time without treatment for the series was 35 months (CI 95%, 15.7-54.2 months). Prolonged hypogonadism (> 24 months) was presented by 17% of the patients. The recovery of the LH-T-PSA axis, when it occurred, followed the expected sequence. The variables that influenced the period of recovery of the PSA were the PSA pretreatment and the association of an antiandrogen.</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">After withdrawing the prolonged treatment with LH-RH analogs, most of the patients recovered the levels of LH-T-PSA, although a subgroup remained hypogonadic for more than 24 months.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:30 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Studies on prostatic cancer: the effect of castration of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Hodges" 1 => "C. Huggins" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Cancer Res" "fecha" => "1941" "volumen" => "1" "paginaInicial" => "293" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized comparison of the clinical hormonal effects of two GnRh agonist in patients with prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Kuhn" 1 => "H. Abourachid" 2 => "P. Brucher" 3 => "J.C. Doutres" 4 => "J. Fretin" 5 => "A. Jaupitre" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Eur Urol" "fecha" => "1997" "volumen" => "32" "numero" => "4" "paginaInicial" => "397" "paginaFinal" => "403" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9412795" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.J. Nejat" 1 => "H.H. Rashid" 2 => "E. Bagiella" 3 => "A.E. Katz" 4 => "M.C. Benson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "J Urol" "fecha" => "2000" "volumen" => "164" "numero" => "6" "paginaInicial" => "1891" "paginaFinal" => "1894" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11061874" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prospective determination of the hormonal response after cessation of luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M.C. Hall" 1 => "R.J. Fritzsch" 2 => "A.I. Sagalowsky" 3 => "A. Ahrens" 4 => "B. Petty" 5 => "C.G. Roehrborn" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Urology" "fecha" => "1999" "volumen" => "53" "paginaInicial" => "898" "paginaFinal" => "902" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10223480" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.G. Oefelein" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Urol" "fecha" => "1998" "volumen" => "160" "paginaInicial" => "1685" "paginaFinal" => "1688" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9783932" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Androgens up-regulate the human prostate-specific antigen messenger ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Henttu" 1 => "S.S. Vihko" 2 => "P. Liao" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1210/endo.130.2.1370795" "Revista" => array:6 [ "tituloSerie" => "Endocrinology" "fecha" => "1992" "volumen" => "130" "paginaInicial" => "766" "paginaFinal" => "772" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1370795" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Phase III intermittent MAB vs continuous MAB" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "F.M. Da Silva Calais" 1 => "F. Da Silva Calais" 2 => "A. Bono" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "J Clin Oncol" "fecha" => "2006" "volumen" => "24" "paginaInicial" => "220" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M.G. Oefelein" 1 => "A. Feng" 2 => "M.J. Scolieri" 3 => "D. Ricchiutti" 4 => "M.I. Resnick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Urology" "fecha" => "2000" "volumen" => "56" "numero" => "6" "paginaInicial" => "1021" "paginaFinal" => "1024" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11113751" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotrophin-releasing hormone agonist in normal men" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "R. Linde" 1 => "G.C. Doelle" 2 => "N. Alexander" 3 => "F. Kirchner" 4 => "W. Vale" 5 => "J. Rivier" 6 => "D. Rabin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "N Eng J Med" "fecha" => "1981" "volumen" => "305" "numero" => "12" "paginaInicial" => "663" "paginaFinal" => "667" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "F. Comite" 1 => "G.B. Cutler Jr." 2 => "J. Rivier" 3 => "W.W. Vale" 4 => "D.L. Loriaux" 5 => "W.F. Crowley Jr." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM198112243052602" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1981" "volumen" => "305" "paginaInicial" => "1546" "paginaFinal" => "1550" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6458765" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Final results of the Canadian Prospective phase II of intermittent androgen suppression for men in biochemical recurrencia after radiotherapy for locally advanced prostare cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Bruchovsky" 1 => "L. Klotz" 2 => "J. Crook" 3 => "S. Malone" 4 => "C. Ludgate" 5 => "W.J. Morris" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncr.21989" "Revista" => array:6 [ "tituloSerie" => "Cancer" "fecha" => "2006" "volumen" => "107" "paginaInicial" => "389" "paginaFinal" => "395" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16783817" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.H. Shaw" 1 => "P. Wilson" 2 => "J. Cuzick" 3 => "D.M. Prowse" 4 => "S.L. Goldenberg" 5 => "N.A. Spry" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1464-410X.2007.06770.x" "Revista" => array:6 [ "tituloSerie" => "BJU Int" "fecha" => "2007" "volumen" => "99" "paginaInicial" => "1056" "paginaFinal" => "1065" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17346277" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Changes in prostate-specific antigen and hormone levels following withdrawal of prolonged androgen ablation for prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Egawa" 1 => "H. Okusa" 2 => "K. Matsumoto" 3 => "K. Suyama" 4 => "S. Baba" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Prostate Cancer Prostatic Dis" "fecha" => "2003" "numero" => "3" "paginaInicial" => "245" "paginaFinal" => "249" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12497027" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Testosterone recovery following prolonged adjuvant androgen ablation for prostate carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Pickles" 1 => "A. Agranovich" 2 => "E. Berthelet" 3 => "G.G. Duncan" 4 => "M. Keyes" 5 => "W. Kwan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncr.10219" "Revista" => array:7 [ "tituloSerie" => "Cancer" "fecha" => "2002" "volumen" => "94" "numero" => "2" "paginaInicial" => "362" "paginaFinal" => "367" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11900222" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and threedimensional conformal radiotherapy for prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.D. Padula" 1 => "M.J. Zelefsky" 2 => "E.S. Venkatraman" 3 => "Z. Fuks" 4 => "H.J. Lee" 5 => "L. Natale" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Int J Radiat Oncol Biol Phys" "fecha" => "2002" "volumen" => "52" "numero" => "2" "paginaInicial" => "439" "paginaFinal" => "443" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11872290" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase II clinia trial using limited hormonal therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.L. Gulley" 1 => "W.D. Figg" 2 => "S.M. Steinberg" 3 => "J. Carter" 4 => "O. Sartor" 5 => "C.S. Higano" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Urol" "fecha" => "2005" "volumen" => "173" "paginaInicial" => "1567" "paginaFinal" => "1571" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15821487" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hormonal pattern and testicular histology in patients with prostatic cancer after long-term treatment with a gonadotropin-releasing hormone agonist analogue" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Giberti" 1 => "T. Barreca" 2 => "G. Martorana" 3 => "M. Truini" 4 => "R. Franceschini" 5 => "E. Rolandi" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Eur Urol" "fecha" => "1988" "volumen" => "15" "numero" => "1-2" "paginaInicial" => "125" "paginaFinal" => "127" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2975220" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reversibility of the effect of LHRH agonists and other antiandrogenic hormones on the testis: a histomorphometric study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "O.K. Kisman" 1 => "H.J. de Voogt" 2 => "J.A. Baak" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Eur Urol" "fecha" => "1990" "volumen" => "18" "numero" => "4" "paginaInicial" => "299" "paginaFinal" => "301" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2127019" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Leydig cell function and radiation: a review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.A. Izard" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Radiother Oncol" "fecha" => "1995" "volumen" => "34" "numero" => "1" "paginaInicial" => "1" "paginaFinal" => "8" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7792393" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of fractionated irradiation of endocrine aspects of testicular function" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E. Shapiro" 1 => "T.J. Kinsella" 2 => "R.W. Makuch" 3 => "B.A. Fraass" 4 => "E. Glatstein" 5 => "S.A. Rosenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Oncol" "fecha" => "1985" "numero" => "9" "paginaInicial" => "1232" "paginaFinal" => "1239" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "V. Murthy" 1 => "A.R. Norman" 2 => "M. Shahidi" 3 => "C.C. Parker" 4 => "A. Horwich" 5 => "R.A. Huddart" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "BJU Int" "fecha" => "2006" "numero" => "3" "paginaInicial" => "476" "paginaFinal" => "479" ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.R. Robinson" 1 => "B.S. Thomas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Br Med J" "fecha" => "1971" "volumen" => "4" "numero" => "5784" "paginaInicial" => "391" "paginaFinal" => "394" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4425892" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hormonal effects of cessation of estrogen treatment for prostatic carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "R. Tomic" 1 => "B. Bergman" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "J Urol" "fecha" => "1987" "volumen" => "138" "numero" => "4" "paginaInicial" => "801" "paginaFinal" => "805" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3116281" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dose escalation with three-dimensionalconformed radiation therapy affectsthe outcome in prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.J. Zelefsky" 1 => "S.A. Leibel" 2 => "P.B. Gaudin" 3 => "G.J. Kutcher" 4 => "N.E. Fleshner" 5 => "E.S. Venkatramen" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Int J Radiat Oncol Biol Phys" "fecha" => "1998" "volumen" => "41" "numero" => "3" "paginaInicial" => "491" "paginaFinal" => "500" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9635694" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prolonged hypogonadism after pulsed gonadotropin-releasing hormone agonist for prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.J. Stevens" 1 => "D.R. Bell" 2 => "S.A. Begbie" 3 => "S.D. Blome" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Lancet" "fecha" => "1994" "volumen" => "344" "numero" => "8917" "paginaInicial" => "274" "paginaFinal" => "275" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7913195" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "M. Shahidi" 1 => "A.R. Norman" 2 => "J. Gadd" 3 => "R.A. Huddart" 4 => "A. Horwich" 5 => "D.P. Dearnaley" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Oncol (R Coll Radiol)" "fecha" => "2001" "volumen" => "13" "numero" => "4" "paginaInicial" => "291" "paginaFinal" => "295" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A controlled trialof leuprolide with and without flutamide in prostatic carcinoma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "E.D. Crawford" 1 => "M.A. Eisenberger" 2 => "D.G. McLeod" 3 => "J.T. Spaulding" 4 => "R. Benson" 5 => "F.A Dorr" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1989" "volumen" => "17" "numero" => "321(7)" "paginaInicial" => "419" "paginaFinal" => "424" ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer. Final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Pavone-Macaluso" 1 => "H.J. de Voogt" 2 => "G. Viggiano" 3 => "E. Barasolo" 4 => "B. Lardennois" 5 => "M. de Pauw" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "J Urol" "fecha" => "1986" "volumen" => "136" "numero" => "3" "paginaInicial" => "624" "paginaFinal" => "631" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2942707" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Histological and functional changes of the testis tissue during GnRH agonist treatment of prostatic cancer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I. Huhtaniemi" 1 => "H. Nikula" 2 => "M. Parvinen" 3 => "S. Rannikko" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Am J Clin Oncol" "fecha" => "1988" "volumen" => "11" "numero" => "Suppl 1" "paginaInicial" => "S11" "paginaFinal" => "15" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/2839028" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib00150" "etiqueta" => "30." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum testosterone-based luteinizing hormonereleasing hormone agonist redosing schedule for chronic androgen ablation: a phase I assessment" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.G. Oefelein" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Urology" "fecha" => "1999" "volumen" => "54" "numero" => "4" "paginaInicial" => "694" "paginaFinal" => "699" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10510930" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/02104806/0000003300000007/v1_201304251940/S0210480609742263/v1_201304251940/es/main.assets" "Apartado" => array:4 [ "identificador" => "6429" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Original" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/02104806/0000003300000007/v1_201304251940/S0210480609742263/v1_201304251940/es/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210480609742263?idApp=UINPBA00004N" "pdfAlternativo" => array:1 [ 0 => array:3 [ "idioma" => "en" "documentoPdf" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/file/02104806/addon/S0210480609742263/S300/en/292v33n07a13143216pdf001_2.pdf" "portada" => "292v33n07a13143216pdf001_2.png" ] ] ]
Información de la revista
Compartir
Descargar PDF
English PDF
Más opciones de artículo
Hipogonadismo prolongado tras la suspensión de tratamiento hormonal en pacientes con cáncer de próstata
Prolonged hypogonadism after cessation of androgen deprivation therapy for prostate cancer
I. Federico Rodríguez-Rubio Cortadellas**
, Miguel E. Jiménez Romero, Delfín González Moreno, Sofía Garrido Insúa
Autor para correspondencia
frubio@pulso.com
Correspondencia autor: Dr. Federico I. Rodríguez-Rubio Cortadellas Servicio de Urología. Hospital Universitario Puerto Real Carretera Nacional IV, Km 665 - 11510 Puerto Real, Cádiz Tel.: 956 005 000
Correspondencia autor: Dr. Federico I. Rodríguez-Rubio Cortadellas Servicio de Urología. Hospital Universitario Puerto Real Carretera Nacional IV, Km 665 - 11510 Puerto Real, Cádiz Tel.: 956 005 000
Área de Medicina Preventiva. Facultad de Medicina. Universidad de Cádiz, España
José P. Novalbos Ruiz*
* Servicio de Urología. Hospital Universitario Puerto Real. Departamento de Cirugía. Universidad de Cádiz, España